Washington Administrative Code
Title 246 - Health, Department of
RADIATION
Chapter 246-240 - Radiation protection Medical use of radioactive material
GENERAL TECHNICAL REQUIREMENTS
Section 246-240-151 - Use of unsealed radioactive material for uptake, dilution, and excretion studies for which a written directive is not required
Current through Register Vol. 24-18, September 15, 2024
Except for quantities that require a written directive under WAC 246-240-060(2), a licensee may use any unsealed radioactive material prepared for medical use for uptake, dilution, or excretion studies that is:
(1) Obtained from a manufacturer, producer, or preparer licensed under WAC 246-235-100(1) or equivalent U.S. NRC or agreement state requirements; or
(2) Prepared by an authorized nuclear pharmacist, or a physician who is an authorized user and who meets the requirements specified in WAC 246-240-163, or 246-240-210 and 246-240-163(3)(a)(ii)(G), or an individual under the supervision of either as specified in WAC 246-240-057; or
(3) Obtained from and prepared by an agreement state or U.S. NRC licensee for use in research in accordance with a radioactive drug research committee-approved protocol or an investigational new drug (IND) protocol accepted by FDA; or
(4) Prepared by the licensee for use in research in accordance with a radioactive drug research committee-approved application or an investigational new drug (IND) protocol accepted by FDA.
Statutory Authority: RCW 70.98.050 and 70.98.080. 09-06-003, § 246-240-151, filed 2/18/09, effective 3/21/09. Statutory Authority: RCW 70.98.050. 07-14-131, § 246-240-151, filed 7/3/07, effective 8/3/07; 06-05-019, § 246-240-151, filed 2/6/06, effective 3/9/06.
